Joyce Sung: Presenting Our Work at The Fertility Society of Australia and New Zealand Annual Meeting 2026
Joyce Sung, Student Researcher at Monash University, shared on LinkedIn:
”It was a privilege to present our work at The Fertility Society of Australia and New Zealand Annual Meeting 2026 in Canberra.
Inositol has become a popular treatment option for PMOS and is the most widely marketed PMOS supplement. While inositol is included as a conditional recommendation in the 2023 International Evidence-based Guideline for the Assessment and Management of PCOS, our review found that a large proportion of studies evaluating inositol do not meet our trustworthiness criteria.
These findings highlight the importance of assessing the trustworthiness of evidence underpinning clinical recommendations, which has direct implications for patient care.
Thank you to Ben Willem Mol, Daniel Rolnik, Nick Brown, Gideon Meyerowitz-Katz, and Madeline Flanagan for their support throughout this process.
Our work will be published soon. I look forward to sharing the full findings and continuing the conversation around data integrity and PMOS treatment.”
Stay informed with the latest updates in fertility and reproductive medicine on Fertility News.
-
Nov 14, 2026, 19:27Katy Encalade: Coaching as an Investment in Ethical Leadership
-
Nov 14, 2026, 19:20Jeyarani Kamaraj: 9 Years of Waiting, 2 Heartbreaking Losses, And Today, 2 Tiny Hands to Hold
-
Nov 14, 2026, 19:12Lynn Burmeister: Why Doctor-Owned Fertility Clinics Matter
-
Nov 14, 2026, 18:36Alejandro González: Positive Test 4 Days After Blastocyst Transfer?
-
Nov 14, 2026, 18:29Danilo Cimadomo: Embryo Transfer Is a Means, Not the Objective Itself
-
Nov 14, 2026, 18:15Ryan Flynn: The Role of Psychosexual Medicine in Fertility Care
-
Nov 14, 2026, 18:04Khalil Faaed: Beyond the PB1 – Post-Denudation Oocyte Morphological Assessment in IVF and ICSI
-
Nov 14, 2026, 17:52Christopher Robinson: A Combined Treatment Strategy for Cesarean Scar Ectopic Pregnancy
-
Nov 14, 2026, 17:40Paul Pirtea: Does the Current Evidence Justify Routine Diagnosis and Treatment of Chronic Endometritis?